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SUMMARY
This study used statistical methods to investigate linkages in phenotypic resistance profiles in a
population sample of 321 Salmonella Typhimurium isolates from sporadic salmonellosis cases in
Lower Saxony, Germany, collected during 2008–2010. A resistance index was applied to calculate
the conditional probability of resistance to one antimicrobial agent given the resistance to one or
more other antimicrobial agent(s). A susceptibility index was defined analogously. A contingency
plot, which visualizes the association between resistances to two antimicrobial agents, facilitated
the interpretation. Linkages between minimum inhibitory concentrations (MIC) were analysed
using Spearman’s rank correlation coefficient and jittered scatter plots. Applying these methods
provided a compact description of multi-resistance and linkages between resistance properties in
large datasets. Moreover, this approach will improve monitoring of antimicrobial resistance
dynamics of bacteria in human or animal populations by identifying linked resistance to
antimicrobial agents (cross- or co-resistance) with a non-molecular method.
Key words : Contingency plot, co-resistance, resistance index, multi-resistance, sporadic
salmonellosis cases.
INTRODUCTION
Antimicrobial resistance is one of the major health
issues in both human and veterinary medicine [1].
Zoonotic bacteria are able to colonize and cause infec-
tions in both humans and animals. As such, they may
be subject to variable selective pressures as imposed
by the use of antimicrobial agents in the different
hosts [2]. In each host, zoonotic bacteria usually live
in a polymicrobial environment, e.g. in the intestinal
tract, where they can acquire various antimicrobial
resistance genes from other bacteria. When zoonotic
bacteria are transferred from an animal host to a
human host by either direct/indirect contact or con-
taminated food, they may not only acquire new re-
sistance genes from bacteria of the human host, but
also pass their own resistance genes to indigenous
bacteria of the human host [2]. Due to EU Zoonoses
Directive 2003/99/EC [3] European Union member
states are responsible for maintaining antimicrobial
resistance monitoring systems for zoonotic bacteria
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with Salmonella enterica being one of the key patho-
gens. Besides giving recommendations on appropriate
choice of therapy, one objective of monitoring and
surveillance programmes is to conduct research to
better understand the emergence and spread of anti-
microbial resistance. For this purpose, antimicrobial
consumption data is collected and the association
between consumption and the number of resistant
bacteria is addressed [4, 5].
The link between the use of antibiotics and bacterial
resistance is well-known, as the effective proliferation
of resistant bacteria is enhanced when selective press-
ures exist [1]. This association has been described in
several studies; e.g. a meta-analysis showing the effect
of antibiotic prescribing in primary care on bacterial
resistance [6] and a cross-national database study
linking resistance levels observed with consumption
of antimicrobial agents in European countries [7].
However, other studies have shown inconsistent re-
sults and the authors concluded that antimicrobial
resistance is influenced by many factors, especially by
linkages between resistance properties [8, 9]. The
knowledge about these linkages should be included in
studies concerning this topic to avoid biased results.
In Salmonella, as in most other bacteria, acquired
resistance to antibiotics can be due to either mutations
in genes, which are relevant for physiological func-
tions in the bacterial cell [e.g. gyrA and parC (fluoro-
quinolone resistance)], or resistance genes whose
products specify a wide variety of resistance mech-
anisms [10, 11]. Many of the known resistance genes
in Salmonella are located on mobile genetic elements,
such as plasmids, transposons, gene cassettes ormobile
genomic islands [12–14] and are easily exchanged be-
tween bacteria living in the same habitat, even in the
absence of direct selective pressure [15, 16]. The latter
aspect plays an important role when resistance genes
are physically linked, co-located on the same mobile
genetic element, and/or are present in gene clusters.
Depending on the host range of the respective mobile
genetic elements, they can be transferred across strain,
species and genus boundaries and thus, contribute to
the dissemination of resistance properties and the de-
velopment of multi-resistance [17, 18].
To detect existing linkages between antimicrobial
resistance properties, the most straightforward ap-
proach is the identification of the resistance genes in
question and the confirmation of their linkage by se-
quence analysis. However, in Salmonella as in various
other Gram-negative pathogens, this is a cumbersome
process since most antimicrobial resistance properties
are encoded by numerous resistance genes accounting
for the same resistance phenotype [11].
In this study, we describe a quantitative, non-
molecular approach, which provides insight into the
linkages between certain resistance properties. We
investigated the question of how associations in ob-
served resistance data could be quantified and whether
the measured associations agree with the knowledge
of existing microbiological cross- and co-resistances
in a recent test population of a relevant zoonotic
pathogen. For this, we determined the resistance
profiles of Salmonella enterica subsp. enterica serovar
Typhimurium isolates from sporadic salmonellosis
human cases in Lower Saxony, Germany, and used
these resistance profiles as an example to identify




In the context of a zoonoses network for research
on enteric pathogens a case-control study on sporadic
S. enterica human infections in Lower Saxony,
Germany was conducted between May 2008 and
January 2010 by the state health department of Lower
Saxony. According to the ProtectionAgainst Infection
Act, Salmonella belong to notifiable pathogens in
Germany. A total of 5708 notified salmonellosis cases,
which were not part of apparent local outbreaks, were
identified in this period and 1802 patients agreed to
participate in the case-control study. Cooperating
sentinel laboratories provided 635 S. enterica isolates,
which were sent to the German National Reference
Centre for Salmonella at the Robert Koch-Institute,
Wernigerode for determination of serotype, phage
type and antimicrobial susceptibility profile.
Antibiotic susceptibility testing
The isolates were tested for antibiotic susceptibility by
broth microdilution according to document 58940-8
of the Deutsches Institut für Normung (DIN) [19].
The isolates were categorized as susceptible (s),
intermediate (i) or resistant (r) on the basis of their
minimum inhibitory concentration (MIC) values using
clinical breakpoints recommended in DIN 58940-4
[19]. If DIN breakpoints were not available, break-
points given in document M100-S20 [20] by the
Clinical Laboratory and Standards Institute (CLSI)
were used. This was the case for nalidixic acid and
158 I. Ruddat and others
kanamycin. As no internationally accepted break-
points exist for streptomycin we used the breakpoints
accepted by the Robert Koch-Institute in their long-
term Salmonella monitoring programmes. The 15
tested antimicrobial agents, the corresponding test
ranges and the breakpoints are listed in Table 1.
Escherichia coli ATCC1 25922 served as quality con-
trol strain. Isolates were classified as multi-resistant
when they exhibited resistance to at least three anti-
microbial agents of different classes/subclasses [21].
Statistical analysis
For calculations with MIC values, we used the fol-
lowing conventions: If the lowest test concentration
of an antimicrobial agent already inhibited growth
of the isolate, the corresponding MIC value was re-
corded as being equal to this concentration. If the
highest concentration of an antimicrobial agent did
not inhibit growth, the corresponding MIC value was
recorded as the next concentration in a twofold di-
lution series (although this next concentration was not
included in the test panel). Correlations between the
observed MIC values of two antimicrobial agents
were measured using Spearman’s rank correlation
coefficient. Two-sided tests regarding the hypotheses
of no correlation were performed using the package
Hmisc [22] in R, version 2.11.1 [23]. In large datasets
small correlation coefficients have already been found
to be statistically significant [24]. Due to graphical
examinations of the relationships, we interpreted
coefficients of o0.5 to be relevant in this context. For
visualization jittered scatter plots were applied by
adding small random numbers to each observation
before plotting [25]. This enabled the illustration
of overlapping data points, which occur due to the
interval-scaled character of MIC values. The ob-
servations are displayed on a log2 scale because the
predefined concentration steps tested in a suscepti-
bility test increased at twofold steps.
Regarding the categorized antimicrobial suscepti-
bility test results, the association between observations
concerning two different antimicrobial agents can
be investigated via contingency tables. For graphical
illustration we used four-stage shadings for rep-
resenting the observed relative frequencies. High fre-
quencies on the main diagonal in such a ‘contingency
plot ’ indicate possible linkages between resistance
properties.
Toquantify the relationship between the categorized
test results, we suggest the following calculations: The
‘resistance index’ is defined as the conditional prob-
ability of an isolate being resistant against all agents
of interest given the probability of an isolate being
resistant against at least one of these agents. In the
two-dimensional case, i.e. comparing two agents, it
can be formalized by
R=P X=r \ Y=rjX=r [ Y=rð Þ=P X=r \ Y=rð Þ
P X=r [ Y=rð Þ ,
where X and Y are two variables representing the
susceptibility test results of two antimicrobial agents.
The index R can be estimated by calculating the ob-
served number of isolates, which are resistant against
both agents, divided by the observed number of
isolates, which are at least resistant against one agent.
In a more-dimensional case, the formula can be
adapted accordingly.
In addition to the resistance index, it is worth
knowing how likely the simultaneous occurrence of
susceptibility to the same antimicrobial agents is. The
‘susceptibility index’ can be formalized analogously
in the two-dimensional case by
S=P X=s \ Y=sjX=s [ Y=sð Þ=P X=s \ Y=sð Þ
P X=s [ Y=sð Þ :
These indices were calculated for each possible two-
dimensional, up to five-dimensional, combination of
antimicrobial agents. Exact confidence intervals for
R and S were computed based on binomial distri-
bution, which holds the chosen confidence level of
95% even if the estimated proportions are near 0 or
near 1 [26].
RESULTS
The most frequently detected serovars were S. Typhi-
murium (n=321, 50.6%) and S. Enteritidis (n=249,
39.2%). The remaining 65 isolates (10.2%) comprised
29 different serovars, of which the most frequent were
S. Infantis (13 isolates) and S. Bovismorbificans (nine
isolates). Of the S. Typhimurium isolates the major
phage types detected were DT193 (n=140), DT120
(n=87) and DT104 (n=26).
The corresponding human host population of
S. Typhimurium isolates consisted of 54.1%males and
45.9% females with 17.0% patients aged <3 years,
39.1% in the 3–14 years age group and 43.9% aged
>14 years. Lower Saxony is a German state where
agriculture and livestock farming have a large impact
of. According to the region type classification scheme
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of the Federal Institute for Research on Building,
Urban Affairs and Spatial Development [27], 21.8%
of patients resided in conurbation areas, 59.3% in
urban areas and 18.9% in rural areas.
The results of susceptibility testing of the 321
S. Typhimurium isolates are shown in Table 1. The
highest percentages of resistance of >75% were
detected for streptomycin, ampicillin, mezlocillin and
oxytetracycline. Low percentages of resistant iso-
lates of 5–14% were detected for nalidixic acid,
mezlocillin+sulbactam, kanamycin, sulfamethoxazole/
trimethoprim and chloramphenicol. All S. Typhi-
murium isolates proved to be susceptible to the ce-
phalosporins: cefotiam, cefotaxime and ceftazidime,
the fluoroquinolone ciprofloxacin, and the amino-
glycosides : gentamicin and amikacin.
Of the 321 S. Typhimurium isolates tested, a
total of 36 different resistance profiles were detected
based on classification as resistant and non-resistant
(=susceptible+intermediate) (Table 2). Forty-nine
(15.3%) isolates were non-resistant to all antimicro-
bial agents tested, whereas 231 (72%) isolates were
classified as multi-resistant by exhibiting resistance
against members of 3–6 classes/subclasses of anti-
microbial agents. Of these, the predominant profile
with 131 (40.8%) isolates was characterized by resis-
tance to penicillins+streptomycin+oxytetracycline.
High linkages between resistance properties
were calculated for any pairwise combination of am-
picillin, mezlocillin, streptomycin and oxytetracycline.
Spearman’s rank correlation coefficients ranged
between 0.56 and 0.81 (Table 3) and the two-
dimensional resistance indices were between 84% and
99% (Fig. 1), with maximum values obtained for the
two penicillins: ampicillin and mezlocillin. Regarding
the four agents combined, the four-dimensional re-
sistance index was calculated as 80%. The corre-
sponding susceptibility index was calculated as 0,
i.e. each isolate was classified as either resistant or
intermediate to at least one of these agents. Multi-
resistance to penicillins (ampicillin and mezlocillin),
streptomycin, oxytetracycline and chloramphenicol
occurred in 13% of S. Typhimurium isolates and the
five-dimensional resistance index was estimated as
16%.Furthermore, some positivemonotonic relation-
ships were measured between any of the two
Table 1. Tested antimicrobial agents, dilution ranges and clinical breakpoints used for analyses and susceptibility












s% i% r% MIC50 MIC90s r
b-Lactams (penicillins) Ampicillin AMP 1–16 f2 o16 21 2 77 2 >16





MSU 2–32 f4 o32 60 31 9 4 16
b-Lactams
[cephalosporins (2nd)]
Cefotiam CTM 0.5–8 f4 o16 100 — — 0.5 0.5
b-Lactams
[cephalosporins (3rd)]
Cefotaxime CTX 1–16 f2 o16 100 — — 1 1
Ceftazidime CAZ 2–32 f4 o32 100 — — 2 2
Quinolones Nalidixic acid NAL 4–32 f16 o32 95 — 5 8 8
Fluoroquinolones Ciprofloxacin CIP 0.0625–64 f1 o4 100 0 — 0.0625 0.0625
Aminoglycosides Streptomycin STR 4–64 f8 o32 6 17 77 16 >64
Kanamycin KAN 2–32 f16 o64 90 0 10 4 8
Gentamicin GEN 0.5–8 f1 o8 94 6 — 0.5 1
Amikacin AMK 2–32 f4 o32 96 4 — 2 4





SXT 4–128 f16 o128 87 0 13 4 8
Phenicols Chloramphenicol CMP 4–32 f8 o16 86 — 14 4 8
s, Susceptible ; i, intermediate ; r, resistant.
‘–’ refers to no isolates ; ‘0 ’ refers to rounded values with small number of isolates.
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penicillins and the combination of mezlocillin+
sulbactam (Table 3), while the resistance index was
relatively low at 11% (Fig. 1). Spearman’s correlation
coefficient regarding nalidixic acid and ciprofloxacin
confirmed some linkages with a value of 0.59. The
jittered scatter plot of MIC values showed, that if
nalidixic acid’s MIC was low, ciprofloxacin’s MIC
was also low (Fig. 2). When nalidixic acid’s MIC
increased to the category ‘resistant ’ (o32 mg/ml),
ciprofloxacin’s MIC value of the same isolate also
showed an increase, although this increase in MIC did
not lead to a classification of the corresponding iso-
lates as resistant. The calculation of the resistance
index is not reasonable for this combination, due to
the fact that no ciprofloxacin-resistant isolates were
present in the study sample.
DISCUSSION
The objective of this study was to explore quantitative
non-molecular methods in order to visualize and de-
scribe linkages between different antimicrobial resist-
ance properties in large datasets. As an example the
resistance profiles of 321 S. Typhimurium isolates
collected from human sporadic salmonellosis cases
were investigated.
Table 2. Observed resistance profiles for S. Typhimurium isolates (n=321) from human cases in Lower Saxony
ordered by frequency
No. Resistance profile Frequency %
1 AMP+MEZ+STR+OTE 131 40.8
2 – 49 15.3
3 AMP+MEZ+STR+OTE+CMP 20 6.2
4 AMP+MEZ+STR+KAN+OTE+SXT 12 3.7
5 AMP+MEZ+NAL+STR+OTE+CMP 10 3.1
6 AMP+MEZ+STR+KAN+OTE 10 3.1
7 AMP+MEZ+STR 10 3.1
8 STR 10 3.1
9 AMP+MEZ+MSU+STR+OTE 8 2.5
10 AMP+MEZ+MSU+OTE+SXT 8 2.5
11 OTE 7 2.2
12 AMP+MEZ+STR+OTE+SXT 6 1.9
13 AMP+MEZ+STR+OTE+SXT+CMP 5 1.6
14 AMP+MEZ+MSU+STR+KAN+OTE+SXT 4 1.2
15 AMP+MEZ 4 1.2
16 STR+OTE 4 1.2
17 AMP+MEZ+MSU+STR+OTE+CMP 3 0.9
18 AMP+STR+OTE 2 0.6
19 AMP+MEZ+MSU+NAL+STR+KAN+OTE+SXT 1 0.3
20 AMP+MEZ+MSU+STR+KAN+OTE+CMP 1 0.3
21 AMP+MEZ+NAL+STR+OTE+SXT+CMP 1 0.3
22 AMP+MEZ+STR+KAN+OTE+SXT+CMP 1 0.3
23 AMP+MEZ+MSU+STR+OTE+SXT 1 0.3
24 AMP+MEZ+STR+KAN+OTE+CMP 1 0.3
25 AMP+MEZ+NAL+STR+OTE 1 0.3
26 AMP+MEZ+NAL+STR+CMP 1 0.3
27 AMP+MEZ+STR+KAN+SXT 1 0.3
28 AMP+MEZ+STR+KAN+CMP 1 0.3
29 AMP+MEZ+MSU+OTE 1 0.3
30 AMP+MEZ+STR+CMP 1 0.3
31 AMP+MEZ+MSU 1 0.3
32 AMP+MEZ+OTE 1 0.3
33 NAL+STR+OTE 1 0.3
34 STR+SXT 1 0.3
35 OTE+SXT 1 0.3
36 SXT 1 0.3
For abbreviations, see Table 1.
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Concerning the representativeness of this sample,
the acquisition of study data can be understood as a
stepwise selection process. The first step was the re-
cruitment of notified cases for participation in the
case-control study with a response of 31.6%. The se-
cond step was a restricted access to a laboratory sen-
tinel, with a further response of 35.2%. Therefore,
selection bias is possible. However, in comparing
the study data with all notified S. Typhimurium
salmonellosis cases in the study period (n=2488,
personnel register communication, data not shown),
both populations show similar distribution of gender
(54.1% vs. 54.2% males). The mean age in both
groups is in young adults (22.0 vs. 28.3 years). In sum-
mary we therefore did not assume a relevant selection
bias for our data and regard it as a representative
sample of all notified sporadic salmonellosis cases
with serovar Typhimurium in the federal state of
Lower Saxony, Germany.
As far as we know the presented methods for
analysis of categorical resistance data have not been
used in the context of describing linkages between
antimicrobial resistance properties up to now. The
suggested contingency plot and indices of resistance
and susceptibility are intuitive, easy to interpret and
flexibly applicable in comparing resistances against
two or more antimicrobial agents. They can be ap-
plied, if clinical breakpoints are used to categorize
the MIC values in three categories ‘susceptible ’,
‘ intermediate’ or ‘resistant ’ or only in the two cat-
egories ‘resistant ’ and ‘non-resistant ’ or ‘susceptible ’
and ‘non-susceptible ’. They can also be applied, if
epidemiological cut-off values for the categories ‘wild
type’ and ‘non-wild type’ are used.
In the presented study we chose clinical break-
points, because only these allow for prediction of
therapy success. Isolates classified as ‘non-wild type’
by using epidemiological cut-off values (isolates that
have an acquired or mutational resistance mechanism
to the drug in question [28]) may show in some cases
MIC values, which classify the isolates as susceptible
when clinical breakpoints are used. This is particu-
larly true for ciprofloxacin. In the context of clinical
breakpoints intermediate isolates are considered in
the definition of resistance index as non-resistant
and in the definition of susceptibility index as non-
susceptible. Therefore the consideration of inter-
mediate isolates is not consistent in the calculation of
both indices, but is consistent in that we do not need
to further classify the intermediate isolates. Instead,
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definition as a buffer zone to prevent misclassification
due to measurement errors [28]. If susceptible or re-
sistant isolates are misclassified as intermediate, this
affects the stability of any statement about the sus-
ceptibility or the resistance of a population. This will
cause a susceptibility or resistance index, which is
unstable as well. In the two-dimensional case, the
amount of intermediate isolates, and therefore the
amount of possible misclassified isolates, is displayed
in the contingency plots (Fig. 1).
The detection of linkages between resistance
properties using these methods is only possible if re-
sistances occur at sufficient frequencies in the isolates
of a given test population. If antimicrobial agents, to
which most isolates are susceptible, are in the focus of
interest, it is of advantage to analyse the quantitative
susceptibility test data (i.e. the MIC values), too. For
this purpose, we chose the commonly used Spearman’s
rank correlation coefficient for non-normal data,
which enables a pair-wise assessment of antimicrobial
agents. In contrast to the categorical data, the MIC
values account for changes below or above the break-
points.
When testing 15 antimicrobial agents and categori-
zing the results as resistant and non-resistant, theo-
retically 215=32 768 different resistance profiles are
possible. In our sample of 321 isolates only 36 profiles
were found (Table 2). This observation confirmed a
high level of association between resistance properties
within the test population and supports the micro-
biological observation that resistance genes are often
genetically linked and/or occur together.
By applying the suggested methods, we were able to
specify these relationships more precisely. The highest
associations regarding both the probability of simul-
taneous occurrence of resistance and susceptibility,
were measured for ampicillin and mezlocillin. Suscep-
tibility test results were identical for both agents in
nearly 97% of the cases and differed only for cases
where one status was intermediate. These penicillins
Frequency coding: < 10% 10% to <30% 30% to <60% ≥ 60%
Fig. 1. Associations between resistance properties for S. Typhimurium isolates (n=321) from human cases in Lower Saxony
to antimicrobial agents which have any observed resistances. Lower diagonal matrix : contingency plots with frequency-based
shading; upper diagonal matrix : calculated indices of resistance (R) and susceptibility (S) with corresponding 95% confi-
dence intervals (for abbreviations, see Table 1).
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share a similar structure and are considered as
b-lactamase-sensitive. Thus, the same b-lactamase is
likely to confer simultaneous resistance to ampicillin
and mezlocillin and such resistance is regarded as
cross-resistance [11, 29]. The most frequent multi-
resistances observed in the test population were those
to ampicillin/mezlocillin, streptomycin and oxytetra-
cycline. If an isolate was resistant to one of these
agents, the probability of it being resistant to all four
agents was calculated as 80%.Moreover, every isolate
had at least one intermediate status and consequently
no isolate was simultaneously susceptible to all four
agents. These high multi-resistance levels could be
explained by similar selective pressures, which have
existed over the last decades since penicillins, tetra-
cyclines and the aminoglycoside streptomycin were
introduced into clinical use in human and veterinary
medicine almost at the same time [30]. Nowadays,
penicillins and tetracyclines represent the two classes
of antimicrobial agents most frequently used in
human and veterinary medicine in Germany [5, 31].
The b-lactamase genes, tetracycline and streptomycin
resistance genes commonly found in Salmonella are
most frequently located on mobile genetic elements
[11]. Often, such genes are found to be co-located on
the same plasmid. The horizontal transfer of such
multi-resistance plasmids results in a simultaneous
transfer of all the resistance genes located on the re-
spective plasmid [11]. Another mobile genetic element
present in Salmonella is the well-studied mobile geno-
mic island SGI1 [32]. Several different SGI1 variants
exist, many of which mediate resistance to peni-
cillin, streptomycin, tetracycline, chloramphenicol/
florfenicol and sulfonamides. SGI1 was initially de-
tected in the chromosomal DNA of S. Typhimurium
DT104, later it was also detected in the chromosomal
DNA of other S. Typhimurium phage types and
S. enterica serovars [33, 34]. The location of resistance
genes on the chromosome rules out the possibility of
losing the resistance property under conditions of low
selective pressure. Therefore, it was not surprising to
observe the resistance profile with multi-resistance to
penicillins, streptomycin, oxytetracycline and chlor-
amphenicol with a prevalence of 85% in the isolates
with phage type DT104 (n=26), despite the fact, that
chloramphenicol is only used rarely in human medi-
cine and has been banned from use in food-producing
animals in the EU since 1994. Of the isolates with
other phage types, for which the presence of this mo-
bile genomic island is less likely, the prevalence was
7% (n=295).
The observed correlations between MIC values but
low calculated resistance indices for the penicillins,
ampicillin and mezlocillin and the combination of
mezlocillin+sulbactam (Table 3, Fig. 1) can be ex-
plained by the characteristic that b-lactamase in-
hibitors, such as sulbactam, are not able to inhibit
all types of b-lactamases [29]. A considerable number
of the 247 ampicillin/mezlocillin-resistant isolates
showed susceptibility to mezlocillin+sulbactam (48%)
whereas 11% showed resistance to mezlocillin+sul-
bactam. This observation suggested that different types
of b-lactamases are present in the S. Typhimurium
isolates tested.
Concerning the observed correlation between
nalidixic acid and ciprofloxacin MIC values, previous
studies demonstrated that resistance to the quinolone
nalidixic acid is based preferentially on single-point
mutations in the quinolone resistance-determining
region of the target gene gyrA [35, 36]. For resistance
to fluoroquinolones such as ciprofloxacin, additional
mutations in further genes are required and clinically
relevant MIC values only appear by the stepwise
combination of differentmutations [32, 37]. Therefore,
ciprofloxacin-resistant isolates are commonly resistant
to nalidixic acid. Non-classical phenotypes with re-
duced ciprofloxacin susceptibility and susceptibility
or low-level resistance to nalidixic acid have been re-
ported in rare cases [38].
Usually, antibiotic therapy is not required to treat
S. enterica infections. However, antibiotics are in-
dicated when children aged up to 2 months, elderly
Fig. 2. Jittered scatter plot of nalidixic acid minimum in-
hibitory concentration (MIC) values and ciprofloxacin MIC
values for S. Typhimurium isolates (n=321) from human
cases in Lower Saxony.
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people or immunocompromised persons are involved
as well as in cases with extraintestinal symptoms.
Fluoroquinolones and third-generation cephalospor-
ins are particularly relevant for treatment. Ampicillin,
the combination of trimethoprim and sulfamethox-
azole and chloramphenicol are occasionally used as
alternatives. Analysing the S. Typhimurium isolates
with regard to this special subset of therapeutically
relevant antimicrobial agents, 22% of isolates were
simultaneously susceptible to all six agents. All isolates
were susceptible to the cephalosporins and cipro-
floxacin and only six isolates were simultaneously re-
sistant to the remaining three agents (Table 2). In
Denmark at least four cases in a 1998 outbreak were
observed in which S. Typhimurium isolates were na-
lidixic acid-resistant and ciprofloxacin non-resistant,
but the treatment with ciprofloxacin failed [39].
Further studies give additional evidence, that nalidixic
acid resistance should be interpreted as an indicator
for possible unreliable ciprofloxacin susceptibility
[40, 41]. Ray et al. [42] showed that nalidixic acid
susceptibility is a good marker for fluoroquinolone
susceptibility whereas nalidixic acid resistance had
only a poor predictive value for ciprofloxacin resist-
ance.
In summary, the results of this study revealed that
the presented analysis tools are appropriate for
assessing the resistance situation and quantifying the
linkages between resistance properties as shown by
using a test population of S. Typhimurium from
sporadic salmonellosis cases. The results are useful for
public health departments with regard to the moni-
toring and surveillance of antimicrobial resistance to
describe the dynamics of resistance properties and
their linkages over time in bacteria of animal or hu-
man populations. To clarify this, the stratified indices
of susceptibility and resistance comparing the study
periods May–December 2008 and May–December
2009 are displayed in Fig. 3. While the majority of
susceptibility indices remained constant or decreased,
Study period: May–December 2009 
Study period: May–December 2008
Fig. 3. Comparison of calculated indices of resistance (R) and susceptibility (S) with corresponding 95% confidence intervals
for S. Typhimurium isolates from human cases in Lower Saxony collected in two study periods : May–December 2008 (lower
diagonal matrix, n=99) and May–December 2009 (upper diagonal matrix, n=95) (for abbreviations, see Table 1).
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two-thirds of resistance indices increased. In spite of
slightly decreasing proportions of multi-resistant iso-
lates during these periods (79.8% vs. 77.9%), the
multi-resistant isolates obtained in the second period
showed more resistances than those obtained in the
first, which caused the observed increase of linked
resistances. However, in order to investigate if these
changes are part of a trend or yearly variation, larger
datasets, e.g. from monitoring programmes are nee-
ded. Moreover, if new, frequently arising resistance
phenotypes are identified, this is a basis for diagnostic
research to conduct sequence analysis for the confir-
mation of the responsible resistance genes and their
organization.
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